Relationship between immune-mediated adverse events and clinical outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors (ICI): A single institution experience.

Authors: Leticia Escobar Vicentini, Mariana Ferrari de Jesus Abdalla, Martinely Ribeiro de Souza Godinho, Bruno Bezerra, Sara Lima, Veridiana Pires De Camargo, Cleyton Z. Oliveira, Antonio C. Buzaid

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21531

Source: Full article

---

Abstract

e21531